Stroger Hospital of Cook County, MBCCOP
库克县斯特罗格医院 MBCCOP
基本信息
- 批准号:8145364
- 负责人:
- 金额:$ 82.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): John H. Stroger Jr, Hospital of Cook County (SHCC) in Chicago, Illinois is the major tertiary care site for the Cook County Health and Hospital System (CCHHS). The majority of cancer cases are from minority-underserved populations, and are predominantly African American. SHCC plans to develop, strengthen and improve coordinated care and clinical research through the growth and expansion of the Minority-Based Community Clinical Oncology Program (MBCCOP). Dr. Thomas E. Lad will continue as Principal Investigator (PI). The SHCC MBCCOP will maintain and nurture relationships with current cancer research bases to facilitate broad and improved participation in treatment and prevention/control trials for breast, lung, prostate, gastrointestinal, brain, hematologic, head and neck, and gynecologic cancers; increase scientific activity at the research base level by initiating and chairing an ECOG group-wide cancer control study concerning reproductive issues of female cancer patients; increase support for oncologists and other cancer related healthcare providers; encourage multidisciplinary cancer care and integrated research; facilitate transfer of state-of-the-are quality oncology care and new technology to minority-underserved populations in their own communities through participation in NCl-approved clinical trials; focus on prevention and control as methods for reducing cancer incidence, morbidity and mortality and extend and promote research involvement and opportunities with emphasis on the particular needs of the community served, promoting outreach and education.
RELEVANCE: The renewal of the Minority-based Community Clinical Oncology Program at SHCC in Chicago is imperative to continue the availability of oncologic clinical trials to the minority-underserved patients of Cook County.
描述(由申请人提供):伊利诺伊州芝加哥库克县(SHCC)医院(SHCC)的John H. Stroger Jr是库克县健康与医院系统(CCHHS)的主要三级护理网站。大多数癌症病例来自少数族裔的人群,主要是非裔美国人。 SHCC计划通过基于少数族裔的社区临床肿瘤学计划(MBCCOP)的增长和扩展来发展,加强和改善协调的护理和临床研究。 Thomas E. Lad博士将继续担任首席研究员(PI)。 SHCC MBCCOP将与当前的癌症研究基础保持和培育关系,以促进乳腺癌,肺,前列腺,胃肠道,脑,血液学,头颈以及妇科癌症的乳腺癌,肺,前列腺,胃肠道,脑,血液学,头颈和妇科癌症的广泛参与/对照试验;通过启动和主持有关女性癌症患者生殖问题的ECOG群体控制研究,提高研究基础的科学活动;增加对肿瘤学家和其他与癌症相关的医疗保健提供者的支持;鼓励多学科的癌症护理和综合研究;通过参加NCL批准的临床试验,促进将最先进的肿瘤学护理和新技术转移到其自己社区中少数群体的人口;专注于预防和控制作为减少癌症发病率,发病率和死亡率的方法,并扩展和促进研究参与和机会,重点关注社区服务的特定需求,从而促进外展和教育。
相关性:芝加哥SHCC的基于少数族裔的社区临床肿瘤计划的续签必须继续向库克县的少数族裔持有的患者进行肿瘤学临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Thomas Lad的其他基金
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:1045353110453531
- 财政年份:2014
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:1067224610672246
- 财政年份:2014
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
库克县斯特罗格医院 (SHCC) MU-NCORP 更新
- 批准号:1022695010226950
- 财政年份:2014
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Stroger Hospital of Cook County, MBCCOP
库克县斯特罗格医院 MBCCOP
- 批准号:83291418329141
- 财政年份:2002
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Stroger Hospital of Cook County, MBCCOP
库克县斯特罗格医院 MBCCOP
- 批准号:83327838332783
- 财政年份:2002
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Stroger Hospital of Cook County, Department of Surgery,*
库克县斯特罗格医院外科,*
- 批准号:79326997932699
- 财政年份:2002
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
相似国自然基金
靶向小胶质细胞的仿生甘草酸纳米颗粒构建及作用机制研究:脓毒症相关性脑病的治疗新策略
- 批准号:82302422
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
HMGB1/TLR4/Cathepsin B途径介导的小胶质细胞焦亡在新生大鼠缺氧缺血脑病中的作用与机制
- 批准号:82371712
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Emerging role of tumor-derived exosomes in immune modulation and breast cancer health disparity.
肿瘤源性外泌体在免疫调节和乳腺癌健康差异中的新作用。
- 批准号:1072664710726647
- 财政年份:2023
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
1/2 Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC)
1/2 加强 NCCU 和 UNC 酒精研究的合作伙伴关系 (PEAR-NC)
- 批准号:1054096210540962
- 财政年份:2022
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Multimodal hybrid nanoparticles for the treatment of triple-negative breast cancer
多模式混合纳米粒子用于治疗三阴性乳腺癌
- 批准号:1051499710514997
- 财政年份:2022
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
2/2 Partnerships to Enhance Alcohol Research Across NCCU and UNC (PEAR-NC)
2/2 加强 NCCU 和 UNC 酒精研究的合作伙伴关系 (PEAR-NC)
- 批准号:1070568510705685
- 财政年份:2022
- 资助金额:$ 82.38万$ 82.38万
- 项目类别:
Development of Novel ERRalpha Antagonists as Breast Cancer Therapeutics
新型 ERRα 拮抗剂作为乳腺癌治疗药物的开发
- 批准号:1051073210510732
- 财政年份:2022
- 资助金额:$ 82.38万$ 82.38万
- 项目类别: